An2 Therapeutics shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in An2 Therapeutics by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $76k | 60k | 1.27 |
| 2025-06-30 | $64k | 60k | 1.06 |
| 2025-03-31 | $82k | 60k | 1.36 |
| 2024-12-31 | $224k | 162k | 1.38 |
| 2024-09-30 | $211k | 197k | 1.07 |
| 2024-06-30 | $224k | 104k | 2.15 |
| 2024-03-31 | $85k | 26k | 3.25 |
| 2023-09-30 | $764k | 48k | 16.08 |
| 2023-06-30 | $234k | 28k | 8.50 |
| 2023-03-31 | $518k | 53k | 9.87 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management